Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin
Br J Cancer. 2025 May 20. doi: 10.1038/s41416-025-03055-9. Online ahead of print.
Published on May 20, 2025
ABSTRACT
BACKGROUND: Cutaneous neurofibromas (cNFs) are the hallmark of the tumor-predisposition syndrome neurofibromatosis 1 (NF1). While cNFs are always benign, they markedly decrease quality of life in individuals with NF1. Understanding the differences between cNFs and the skin is essential for developing treatments for cNFs.
METHODS: We collected 15 cNFs from four NF1 individuals and used mass spectrometry to compare the tumor tissue with the skin overlying each tumor. Data were analyzed based on Gene Ontology (GO) terms.
RESULTS: The expression patterns of the Schwann cell marker S100B and several keratins confirmed successful dissection of cNF tissue from the overlying skin. Hierarchical clustering showed extensive overlap between the tumor and skin samples in three out of four individuals, suggesting high overall similarity between the two tissue types. Based on the analysis of the GO terms, cNFs were associated with decreased expression of proteins related to cell proliferation, extracellular matrix remodeling, angiogenesis and cellular metabolism.
CONCLUSION: The cNFs are relatively quiescent, consistent with their benign nature and limited growth potential. The development of pharmacological therapy for cNFs requires overcoming the high similarity between cNFs and the overlying skin. The present dataset can serve as a resource for future research on cNFs.
PMID:40394150 | DOI:10.1038/s41416-025-03055-9
Latest Publications
- A resource to empirically establish drug exposure records directly from untargeted metabolomics data
- Microbiome-derived bile acid signatures in early life and their association with islet autoimmunity
- Mitochondria-Targeted Nanomotor: H2S-Driven Cascade Therapy for Hepatocellular Carcinoma
- Regulation of cell dynamics by rapid integrin transport through the biosynthetic pathway
- JNK-regulated phosphoproteome links synaptic and metabolic pathways to mood regulation